Akari Therapeutics PlcAkari Therapeutics PlcAkari Therapeutics Plc

Akari Therapeutics Plc

No trades
No trades

Compare with Akari Therapeutics Plc


Market capitalization
‪15.06 M‬USD
‪−17.34 M‬USD
0.00USD
‪1.14 M‬
Beta (1Y)
3.99
Next report date
Report period
EPS estimate
Revenue estimate

Profile


CEO
Abizer Gaslightwala
Headquarters
Tampa
Founded
2004
ISIN
US00972G4055
CUSIP
00972G405
FIGI
BBG003PMV495
Identifiers
ISIN US00972G4055
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.